Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.

Literature DB >> 22244459

Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.

Bita Arabshahi¹, Robert A Silverman, Olcay Y Jones, Lisa G Rider.

Abstract

We report the successful use of abatacept and sodium thiosulfate in a patient with severe recalcitrant juvenile dermatomyositis complicated by ulcerative skin disease and progressive calcinosis. This combination therapy resulted in significant reductions in muscle and skin inflammation, decreased corticosteroid dependence, and halted the progression of calcinosis. Copyright Â

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 22244459 PMCID： PMC3306811 DOI： 10.1016/j.jpeds.2011.11.057

Source DB: PubMed Journal: J Pediatr ISSN： 0022-3476 Impact factor: 4.406

10 in total

1. Topical sodium thiosulfate therapy for leg ulcers with dystrophic calcification.

Authors: Elizabeth K Wolf; Aimee C Smidt; Anne E Laumann
Journal: Arch Dermatol Date: 2008-12

2. Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells.

Authors: K Nagaraju; N Raben; M L Villalba; C Danning; L A Loeffler; E Lee; N Tresser; A Abati; P Fetsch; P H Plotz
Journal: Clin Immunol Date: 1999-08 Impact factor: 3.969

Review 3. Immunopathogenesis of juvenile dermatomyositis.

Authors: Sahil Khanna; Ann M Reed
Journal: Muscle Nerve Date: 2010-05 Impact factor: 3.217

4. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis.

Authors: Nicolino Ruperto; Daniel J Lovell; Pierre Quartier; Eliana Paz; Nadina Rubio-Pérez; Clovis A Silva; Carlos Abud-Mendoza; Ruben Burgos-Vargas; Valeria Gerloni; Jose A Melo-Gomes; Claudia Saad-Magalhães; J Chavez-Corrales; Christian Huemer; Alan Kivitz; Francisco J Blanco; Ivan Foeldvari; Michael Hofer; Gerd Horneff; Hans-Iko Huppertz; Chantal Job-Deslandre; Anna Loy; Kirsten Minden; Marilynn Punaro; Alejandro Flores Nunez; Leonard H Sigal; Alan J Block; Marleen Nys; Alberto Martini; Edward H Giannini
Journal: Arthritis Rheum Date: 2010-06

5. Successful treatment of severe iatrogenic calcinosis cutis with intravenous sodium thiosulfate in a child affected by T-acute lymphoblastic leukemia.

Authors: Colombatti Raffaella; Calò Annapaola; Iacopetti Tullio; Rosolen Angelo; Lombardi Giuseppe; Cesaro Simone
Journal: Pediatr Dermatol Date: 2009 May-Jun Impact factor: 1.588

Review 6. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy.

Authors: Georg Schlieper; Vincent Brandenburg; Markus Ketteler; Jürgen Floege
Journal: Nat Rev Nephrol Date: 2009-09 Impact factor: 28.314

Review 7. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.

Authors: Lucy R Wedderburn; Lisa G Rider
Journal: Best Pract Res Clin Rheumatol Date: 2009-10 Impact factor: 4.098

Review 8. Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept.

Authors: Ugo Fiocco; Paolo Sfriso; Francesca Oliviero; Elisa Pagnin; Elena Scagliori; Carla Campana; Serena Dainese; Luisella Cozzi; Leonardo Punzi
Journal: Autoimmun Rev Date: 2008-08-15 Impact factor: 9.754

9. Successful treatment of calcific uremic arteriolopathy in a pediatric dialysis patient.

Authors: Nimisha Amin; Elsa Gonzalez; Michael Lieber; Isidro B Salusky; Joshua J Zaritsky
Journal: Pediatr Nephrol Date: 2009-11-03 Impact factor: 3.714

10. CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production.

Authors: Maurizio Cutolo; Stefano Soldano; Paola Montagna; Alberto Sulli; Bruno Seriolo; Barbara Villaggio; Pierfranco Triolo; Paolo Clerico; Lamberto Felli; Renata Brizzolara
Journal: Arthritis Res Ther Date: 2009-11-23 Impact factor: 5.156

10 in total

29 in total

Review 1. The presentation, assessment, pathogenesis, and treatment of calcinosis in juvenile dermatomyositis.

Authors: Mark F Hoeltzel; Edward J Oberle; Angela Byun Robinson; Arunima Agarwal; Lisa G Rider
Journal: Curr Rheumatol Rep Date: 2014-12 Impact factor: 4.592

Review 2. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.

Authors: Siamak Moghadam-Kia; Rohit Aggarwal; Chester V Oddis
Journal: Expert Rev Clin Immunol Date: 2015-08-27 Impact factor: 4.473

Review 3. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

Authors: Lisa G Rider; James D Katz; Olcay Y Jones
Journal: Rheum Dis Clin North Am Date: 2013-09-19 Impact factor: 2.670

Review 4. Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment.

Authors: Jian-Qiang Wu; Mei-Ping Lu; Ann M Reed
Journal: World J Pediatr Date: 2019-09-26 Impact factor: 2.764

Review 5. Treatment in myositis.

Authors: Chester V Oddis; Rohit Aggarwal
Journal: Nat Rev Rheumatol Date: 2018-03-29 Impact factor: 20.543

Review 9. Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications.

Authors: E M Moran; F L Mastaglia
Journal: Clin Exp Immunol Date: 2014-12 Impact factor: 4.330

Review 10. Idiopathic inflammatory myopathies.

Authors: Mazen M Dimachkie; Richard J Barohn; Anthony A Amato
Journal: Neurol Clin Date: 2014-08 Impact factor: 3.806